Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/1995
10/31/1995CA2010037C Dual-action tablet
10/30/1995CA2122551A1 Clearing of atherosclerosis
10/26/1995WO1995028474A1 Dna encoding bradykinin b1 receptor
10/26/1995WO1995028426A2 Peptides for reducing or inhibiting bone resorption, angiogenesis and restenosis
10/26/1995WO1995028422A1 Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors
10/26/1995WO1995028418A2 Tachykinin antagonists
10/26/1995WO1995028406A1 Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them
10/26/1995WO1995028387A1 Benzamide compound and medicinal use thereof
10/26/1995WO1995028174A1 The combination of growth hormone and insulin-like growth factor, for treating congestive heart failure
10/26/1995WO1995028173A1 Treatment of congestive heart failure
10/26/1995WO1995028160A1 Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
10/26/1995DE4410997A1 Pharmazeutische Zubereitungen und Arzneistoffe zur Prävention und Behandlung endothelialer Dysfunktionen Pharmaceutical drugs for the prevention and treatment of endothelial dysfunction
10/26/1995CA2188180A1 Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors
10/26/1995CA2187642A1 Peptides for reducing or inhibiting bone resorption, angiogenesis and restenosis
10/26/1995CA2183991A1 Tachykinin antagonists
10/25/1995EP0678503A1 Delta-amino-gamma-hydroxy-omega-aryl alkanoic acid amides with enzyme especially renin inhibiting activities
10/25/1995EP0678122A1 Recombinant anti-vla4 antibody molecules
10/25/1995EP0678090A1 Piperazine derivatives
10/25/1995EP0678027A1 Anti-atherosclerotic agents
10/25/1995EP0678020A1 Compositions comprising cholesterol lowering agents and antioxidants
10/25/1995CN1110685A Nitrogen-containing spirocycles
10/24/1995USRE35072 4-substituted pyrazolo[3,4-d]pyrimidine derivatives
10/24/1995US5461146 Enzyme inhibitor protecting nerve cells from degeneration
10/24/1995US5461066 Antiarrthythmic agent
10/24/1995US5461045 Treating thrombosis, arteriosclerosis, ischemic heart diseases, gastric ulcer and hypertension
10/24/1995US5460829 Fine particle size
10/24/1995US5460820 Methods for providing testosterone and optionally estrogen replacement therapy to women
10/24/1995US5460605 Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist
10/24/1995CA1337432C Method of lowering the blood pressure
10/24/1995CA1337429C Derivatives of 2,2'-iminobisethanol
10/24/1995CA1337425C Substituted (n-ethylamino)methyl-1,2,3,4- tetrahydronaphthalene compounds having alpha-2 adrenergic antagonist activity
10/24/1995CA1337415C Indole derivatives
10/21/1995CA2147429A1 Piperidine derivatives and anti-platelet agents containing the same
10/19/1995WO1995027793A1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1β CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE II (ICErel-II)
10/19/1995WO1995027792A1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1β CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE III (ICErel-III)
10/19/1995WO1995027781A1 Superoxide dismutase-4
10/19/1995WO1995027724A1 An equilin double bond isomer from the acid isomerization of equilin
10/19/1995WO1995027706A1 Novel compounds having a benzisoselen-azoline and -azine structure, method for preparing same and therapeutic uses thereof
10/19/1995WO1995027503A1 Antirestenosis protein
10/19/1995WO1995027496A1 Vasoactive intestinal polypeptide
10/19/1995WO1995027490A1 Use of serotonin antagonists (5ht3) for treating fibromyalgia
10/19/1995WO1995017904A3 Botulinum toxins for treating various disorders and associated pain
10/19/1995CA2187635A1 Superoxide dismutase-4
10/19/1995CA2187322A1 Vasoactive intestinal polypeptide
10/19/1995CA2186486A1 An equilin double bond isomer from the acid isomerization of equilin
10/18/1995EP0677516A1 Cyclic amide derivatives
10/18/1995EP0677514A1 New cyclopropyl derivatives, preparation method thereof and applications
10/18/1995EP0677291A2 Composition and method containing optically pure (S) metoprolol
10/18/1995EP0677107A1 Clotting inhibitor made from protostomia saliva.
10/18/1995EP0677060A1 Peptide inhibitors of cell adhesion
10/18/1995EP0677059A1 Endothelin converting enzyme inhibitors
10/18/1995EP0677051A1 Derivatives of benzoylecgonine, ecgonine and ecgonidine as medicines
10/18/1995EP0677043A1 Platelet aggregation inhibiting compounds
10/18/1995EP0677041A1 Chemical compounds
10/18/1995EP0677039A1 Cyclobutane derivatives as inhibitors of squalene synthetase and protein farnesyltransferase
10/18/1995EP0676964A1 Nitrosylation of protein sh groups and amino acid residues as a therapeutic modality
10/18/1995EP0676961A1 Use of macrolides for the treatment of cerebral ischemia
10/18/1995EP0676960A1 Cycloalkyl amine bis-aryl squalene synthase inhibitors
10/18/1995EP0676959A1 Endothelin receptor antagonists
10/18/1995CN1110149A Compound tsaoko injection and preparation method thereof
10/18/1995CN1110138A Traditional Chinese Medicine preparation for curing angiocardiopathy or cerebrovascular disease
10/17/1995US5459236 Vasoactive vasotocin derivatives
10/17/1995US5459156 Angiotensin converting enzyme inhibitors, hypotensive, atherosclerosis
10/17/1995US5459152 Platelet activating factor antagonists
10/17/1995US5459148 Cardiovascular disorders
10/17/1995US5459147 Angeotensin-antagonistic effects; hypotensive, antiischemic, and antidiabetic agents, treating glaucoma
10/17/1995US5459142 Pyrazinyl and piperazinyl substituted pyrazine compounds
10/17/1995US5459137 Muscle relaxants, anticonvulsants, neuroprotective agents
10/17/1995US5459128 Restenosis inhibitors
10/17/1995CA1337348C Optically active 20,21-dinoreburnamenin derivatives; process for preparing the same; use thereof as drugs and pharmaceutical compositions containing them
10/17/1995CA1337346C Process for preparing 1,5-benzothiazepine derivatives
10/12/1995WO1995027070A1 Dna expression vectors for use in the treatment of vascular diseases by gene therapy
10/12/1995WO1995027053A1 α-1-ANTICHYMOTRYPSIN ANALOGUES HAVING CHYMASE INHIBITING ACTIVITY
10/12/1995WO1995026960A1 Physiologically active substance ei-1507
10/12/1995WO1995026957A1 N-heterocyclyl sulphonamide derivatives and their use as endothelin antagonists
10/12/1995WO1995026731A1 Treating cardiovascular disease with steroidal 5-alpha-reductase inhibitors
10/12/1995WO1995026726A1 Pharmaceutical composition containing a class iii antiarrhythmic agent and a class iv antiarrhythmic agent
10/12/1995WO1995026725A1 Pharmaceutical preparations and medicaments for the prevention and treatment of endothelial dysfunction
10/12/1995WO1995026716A1 Pyrimidine or triazine carboxylic acid derivatives to be used as medicaments
10/12/1995WO1995025091A3 Nipecotic acid derivatives as antithrombic compounds
10/12/1995CA2186783A1 Pharmaceutical preparations and medicinal substances for the prevention and treatment of endothelial dysfunctions
10/12/1995CA2186635A1 .alpha.-1-antichymotrypsin analogues having chymase inhibiting activity
10/11/1995EP0676395A2 Substituted N-heteroaroylguanidines, as inhibitors of sodium-hydrogen exchange, as antiarrhythmic agents and as inhibitors of the proliferation of cells
10/11/1995EP0676204A1 Combinations of an organic nitrate and a salicylate
10/11/1995EP0676197A2 Gamma-linolenic acid for the preparation of a medicament for prevention reocclution of arteries
10/11/1995EP0675902A1 Endothelin antagonists
10/11/1995EP0675896A1 Purine derivatives
10/11/1995EP0675892A1 Novel phosphorus-containing spin-trap compositions
10/11/1995EP0675886A1 Aminomethylene substituted non-aromatic heterocycles and use as substance p antagonists
10/11/1995EP0675883A1 Piperidine derivatives as calcium channel antagonists
10/11/1995EP0675735A1 Method for modulating transendothelial migration of cells promoting inflammation, and related methods of measurement thereof
10/11/1995EP0675732A1 Use of relaxin as therapeutic or preventing agent
10/11/1995EP0675721A1 Pharmaceutical compositions comprising contignasterol compounds
10/11/1995EP0474817B1 Bicyclo [3.3.0]octane derivatives, process for producing them and their pharmaceutical use
10/11/1995CN1110056A Carbostyril derivatives
10/11/1995CN1109889A New sulfuric acid esters of sugar alcohols
10/11/1995CN1109880A 3-(2-aminoethyl)-4-|3-(trifluoromethyl) benzoyl¨-3,4-dihydro-1,4-benzoxazine derivative and preparation of same
10/11/1995CN1109874A Isopropyl 2-methoxyethyl 4-(2-chloro-3-cyano-phenyl)-1,4-dihydro-2,6-dimethyl-pyridine3,5-dicarboxylate
10/11/1995CN1109872A Substituted benzenesulfonylureas and -thioureas, preparation processes and possible uses of pharmaceutical preparations b ased on these compounds
10/11/1995CN1109870A N-(3-aminopropyl)-N-phenyl-5,6,7,8-tetrahydronaphtalene-2-carboxamide derivative, preparation and application of same
1 ... 1419 1420 1421 1422 1423 1424 1425 1426 1427 1428 1429 1430 1431 1432 1433 1434 1435 1436 1437 1438 1439 ... 1595